Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib

Title
Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib
Authors
Keywords
-
Journal
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 137, Issue 4, Pages 951-954
Publisher
Elsevier BV
Online
2016-11-23
DOI
10.1016/j.jid.2016.10.044

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started